Leonardo Calzetti

Founding Partner
CEO of BluPhytal and RareInsight

With more than 30 years in the pharmaceutical industry, Leonardo brings an extensive knowledge of the commercial process and a solid experience in pharma companies start-up and management.
Leonardo is founder of BluPhytal, a company which, through its Rare Insight Consulting division, supports healthcare companies to develop their presence in the Orphan Disease arena.

From 2016 to 2019 Leonardo has served as Head of Global Rare Diseases Franchise at Chiesi, managing the Strategic Marketing process and supporting Business Development activities.
From 2008 to 2015 Leonardo has created and developed the Italian affiliate of Swedish Orphan Biovitrum (SOBI), managing also Greece and Malta territories. In this role Leonardo has represented SOBI into Assobiotec (Italian Association for the Development of Biotechnologies) becoming member of the directive board.

Previously has spent 20 years in Chiesi Farmaceutici in positions with increasing responsibility in operational and strategic marketing, mainly in rare or severe diseases.